Skip to content

The Impact of Lavender Essential Oil Inhalation on the Quality of Recovery in the Post-Anesthesia Period: A Randomized Controlled Trial Combining Physiological and Cognitive Assessments

The Impact of Lavender Essential Oil Inhalation on the Quality of Recovery in the Post-Anesthesia Period: A Randomized Controlled Trial Combining Physiological and Cognitive Assessments

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500111331
Enrollment
Unknown
Registered
2025-10-29
Start date
2025-11-01
Completion date
Unknown
Last updated
2025-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Impact of Recovery Quality During the Post-Anesthetic Phase

Interventions

Lavender Group:The day before surgery, visit the patient and assess their anxiety levels and cognitive function. Upon the patients arrival in the operating room, establish standard monitoring (blood p
Control Group:The day before surgery, the patient is visited to assess anxiety levels and cognitive function. Standard monitoring (blood pressure, heart rate, systolic pressure, diastolic pressure, me

Sponsors

The First Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Age between 18 and 65 years; 2. ASA I–III; 3. Patients undergoing elective surgery with a duration of 60–240 minutes, requiring admission to the Post-Anesthesia Care Unit (PACU); 4. No severe mental illness, cognitive impairment, or olfactory disorders before surgery; 5. No hearing impairment and able to read and write; 6. Patients voluntarily participate in clinical research and have signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Previous allergy or intolerance to lavender essential oils during the perioperative period; 2. Presence of central nervous system or psychiatric disorders, or currently taking psychiatric medications; 3. Severe liver or kidney dysfunction, or other systemic diseases; 4. Patients unable to cooperate with completing the study assessments; 5. Individuals who refuse to participate in this study; 6. Pregnancy.

Design outcomes

Primary

MeasureTime frame
Postoperative 24-hour recovery quality score;Montreal Cognitive Assessment (MoCA) score ;

Secondary

MeasureTime frame
Vital signs;Visual Analog Scale (VAS) score ;Ramsay Sedation Scale score ;Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) Score ;Postoperative Nausea and Vomiting (PONV) Score;Generalized Anxiety Disorder 7-item Scale (GAD-7) score ;Masimo values;Recovery duration;

Countries

China

Contacts

Public ContactYan Li

The First Affiliated Hospital of Anhui Medical University

yanliayfy1988@163.com+86 150 5514 9883

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026